Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
Qi Li(China Pharmaceutical University), Haopeng Sun(China Pharmaceutical University), Yao Chen(Central South University), Hongyu Yang(China Pharmaceutical University)
Cited by 307
Related Papers
Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200
Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
|Journal of Medicinal Chemistry|2021|196
Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application
|Journal of Medicinal Chemistry|2024|173